著者検索結果

1

The challenge of HIV treatment in an era of polypharmacy 著者: David Back, Catia Marzolini

出版事項 2020

全文の入手全文の入手
Revisão

お気に入りに追加

保存先:
2

Interaction Between Amiodarone and Sofosbuvir-based Treatment for Hepatitis C Virus Infection: Potential Mechanisms and Lessons to be Learned 著者: David Back, David M. Burger

出版事項 2015

全文の入手全文の入手
Carta

お気に入りに追加

保存先:
3

New directly acting antivirals for hepatitis C: potential for interaction with antiretrovirals 著者: Kay Seden, David Back, Saye Khoo

出版事項 2010

全文の入手全文の入手
Artigo

お気に入りに追加

保存先:
4

Maraviroc: Pharmacokinetics and drug Interactions 著者: Sylvie Abel, David Back, Manoli Vourvahis

出版事項 2009

全文の入手全文の入手
Artigo

お気に入りに追加

保存先:
5

Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes 著者: Victoria A. Eagling, John Tjia, David Back

出版事項 1998

全文の入手
Artigo

お気に入りに追加

保存先:
6

Modulation of P-glycoprotein function in human lymphocytes and Caco-2 cell monolayers by HIV-1 protease inhibitors 著者: Louise Profit, Victoria A. Eagling, David Back

出版事項 1999

全文の入手
Artigo

お気に入りに追加

保存先:
7

Differential inhibition of cytochrome P450 isoforms by the protease inhibitors, ritonavir, saquinavir and indinavir 著者: Victoria A. Eagling, David Back, Michael Barry

出版事項 1997

全文の入手全文の入手
Artigo

お気に入りに追加

保存先:
8

Darunavir: Pharmacokinetics and Drug Interactions 著者: David Back, Vanitha Sekar, Richard M. W. Hoetelmans

出版事項 2008

全文の入手全文の入手
Artigo

お気に入りに追加

保存先:
9

Pharmacokinetics of Antiretroviral Drugs in Anatomical Sanctuary Sites: The Fetal Compartment (Placenta and Amniotic Fluid) 著者: Laura Else, Stephen Taylor, David Back, Saye Khoo

出版事項 2011

全文の入手全文の入手
Revisão

お気に入りに追加

保存先:
10

Comparison of the induction profile for drug disposition proteins by typical nuclear receptor activators in human hepatic and intestinal cells 著者: Philip Martin, R Riley, David Back, Andrew Owen

出版事項 2007

全文の入手全文の入手
Artigo

お気に入りに追加

保存先:
11

Cobicistat versus ritonavir boosting and differences in the drug–drug interaction profiles with co-medications 著者: Catia Marzolini, Sara Gibbons, Saye Khoo, David Back

出版事項 2016

全文の入手全文の入手
Artigo

お気に入りに追加

保存先:
12

Differences in the cytochrome <i>P</i>-450 isoenzymes involved in the 2-hydroxylation of oestradiol and 17 α-ethinyloestradiol. Relative activities of rat and human liver enzymes 著者: S. Ball, Lesley M. Forrester, C. Roland Wolf, David Back

出版事項 1990

全文の入手
Artigo

お気に入りに追加

保存先:
13

Stopping antiretroviral therapy 著者: Stephen Taylor, Marta Boffito, Saye Khoo, Erasmus Smit, David Back

出版事項 2007

全文の入手
Revisão

お気に入りに追加

保存先:
14

Pharmacokinetics and Drug–Drug Interactions of Long-Acting Intramuscular Cabotegravir and Rilpivirine 著者: Daryl Hodge, David Back, Sara Gibbons, Saye Khoo, Catia Marzolini

出版事項 2021

全文の入手全文の入手
Revisão

お気に入りに追加

保存先:
15

Effects of drugs on 2',3'-dideoxy-2',3'-didehydrothymidine phosphorylation in vitro 著者: Patrick G. Hoggard, Stephen Kewn, Michael Barry, Saye Khoo, David Back

出版事項 1997

全文の入手全文の入手
Artigo

お気に入りに追加

保存先:
16

Saquinavir pharmacokinetics alone and in combination with nelfinavir in HIV-infected patients 著者: Concepta Merry, Michael Barry, Fiona Mulcahy, Kathryn L. Halifax, David Back

出版事項 1997

全文の入手
Carta

お気に入りに追加

保存先:
17

Induction of Influx and Efflux Transporters and Cytochrome P450 3A4 in Primary Human Hepatocytes by Rifampin, Rifabutin, and Rifapentine 著者: Beth Williamson, Kelly E. Dooley, Yuan Zhang, David Back, Andrew Owen

出版事項 2013

全文の入手
Artigo

お気に入りに追加

保存先:
18

The pharmacokinetics of methadone in HIV‐positive patients receiving the non‐nucleoside reverse transcriptase inhibitor efavirenz 著者: S Clarke, Fiona Mulcahy, John Tjia, Helen Reynolds, Sara E. Gibbons, Michael Barry, David Back

出版事項 2001

全文の入手全文の入手
Artigo

お気に入りに追加

保存先:
19

Pharmacokinetic Interactions of Nevirapine and Methadone and Guidelines for Use of Nevirapine to Treat Injection Drug Users 著者: S Clarke, Fiona Mulcahy, John Tjia, Helen Reynolds, Sara E. Gibbons, Michael Barry, David Back

出版事項 2001

全文の入手全文の入手
Artigo

お気に入りに追加

保存先:
20

Stopping lopinavir/ritonavir in COVID-19 patients: duration of the drug interacting effect 著者: Felix Stader, Saye Khoo, Marcel Stoeckle, David Back, Hans H. Hirsch, Manuel Battegay, Catia Marzolini

出版事項 2020

全文の入手全文の入手
Carta

お気に入りに追加

保存先:

検索結果 - David Back

The challenge of HIV treatment in an era of polypharmacy 著者: David Back, Catia Marzolini

Interaction Between Amiodarone and Sofosbuvir-based Treatment for Hepatitis C Virus Infection: Potential Mechanisms and Lessons to be Learned 著者: David Back, David M. Burger

New directly acting antivirals for hepatitis C: potential for interaction with antiretrovirals 著者: Kay Seden, David Back, Saye Khoo

Maraviroc: Pharmacokinetics and drug Interactions 著者: Sylvie Abel, David Back, Manoli Vourvahis

Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes 著者: Victoria A. Eagling, John Tjia, David Back

Modulation of P-glycoprotein function in human lymphocytes and Caco-2 cell monolayers by HIV-1 protease inhibitors 著者: Louise Profit, Victoria A. Eagling, David Back

Differential inhibition of cytochrome P450 isoforms by the protease inhibitors, ritonavir, saquinavir and indinavir 著者: Victoria A. Eagling, David Back, Michael Barry

Darunavir: Pharmacokinetics and Drug Interactions 著者: David Back, Vanitha Sekar, Richard M. W. Hoetelmans

Pharmacokinetics of Antiretroviral Drugs in Anatomical Sanctuary Sites: The Fetal Compartment (Placenta and Amniotic Fluid) 著者: Laura Else, Stephen Taylor, David Back, Saye Khoo

Comparison of the induction profile for drug disposition proteins by typical nuclear receptor activators in human hepatic and intestinal cells 著者: Philip Martin, R Riley, David Back, Andrew Owen

Cobicistat versus ritonavir boosting and differences in the drug–drug interaction profiles with co-medications 著者: Catia Marzolini, Sara Gibbons, Saye Khoo, David Back

Differences in the cytochrome <i>P</i>-450 isoenzymes involved in the 2-hydroxylation of oestradiol and 17 α-ethinyloestradiol. Relative activities of rat and human liver enzymes 著者: S. Ball, Lesley M. Forrester, C. Roland Wolf, David Back

Stopping antiretroviral therapy 著者: Stephen Taylor, Marta Boffito, Saye Khoo, Erasmus Smit, David Back

Pharmacokinetics and Drug–Drug Interactions of Long-Acting Intramuscular Cabotegravir and Rilpivirine 著者: Daryl Hodge, David Back, Sara Gibbons, Saye Khoo, Catia Marzolini

Effects of drugs on 2',3'-dideoxy-2',3'-didehydrothymidine phosphorylation in vitro 著者: Patrick G. Hoggard, Stephen Kewn, Michael Barry, Saye Khoo, David Back

Saquinavir pharmacokinetics alone and in combination with nelfinavir in HIV-infected patients 著者: Concepta Merry, Michael Barry, Fiona Mulcahy, Kathryn L. Halifax, David Back

Induction of Influx and Efflux Transporters and Cytochrome P450 3A4 in Primary Human Hepatocytes by Rifampin, Rifabutin, and Rifapentine 著者: Beth Williamson, Kelly E. Dooley, Yuan Zhang, David Back, Andrew Owen

The pharmacokinetics of methadone in HIV‐positive patients receiving the non‐nucleoside reverse transcriptase inhibitor efavirenz 著者: S Clarke, Fiona Mulcahy, John Tjia, Helen Reynolds, Sara E. Gibbons, Michael Barry, David Back

Pharmacokinetic Interactions of Nevirapine and Methadone and Guidelines for Use of Nevirapine to Treat Injection Drug Users 著者: S Clarke, Fiona Mulcahy, John Tjia, Helen Reynolds, Sara E. Gibbons, Michael Barry, David Back

Stopping lopinavir/ritonavir in COVID-19 patients: duration of the drug interacting effect 著者: Felix Stader, Saye Khoo, Marcel Stoeckle, David Back, Hans H. Hirsch, Manuel Battegay, Catia Marzolini

検索ツール:

関連主題